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Abstract: Oligosaccharides support gut development and bacterial colonization in term infants, but it
is unknown if they benefit preterm infants. Using preterm pigs, we investigated effects of bovine
milk supplements enriched with oligosaccharides to improve gut development and colonization.
Caesarean-delivered preterm pigs (n = 57) were reared for 19 days. The pigs were fed bovine milk
supplemented with an oligosaccharide-enriched whey containing sialyllactose, or a heterogeneous
oligosaccharide ingredient. To evaluate the influence of artificial rearing, near-term, vaginally
born pigs raised by their sow (n = 12) were compared with artificially reared, caesarean-delivered
near-term pigs (n = 14). In preterm pigs, the clinical outcome, gut function, gut microbiota,
and systemic immunity were similar among dietary treatments. Natural rearing increased growth
rates, gut functions, colon short chain fatty acid concentrations and bacterial diversity, relative
to artificial rearing. In conclusion, supplements with bovine milk oligosaccharides were well
tolerated, but did not improve gut maturation or clinical outcomes in artificially reared preterm
piglets. Immaturity at birth, coupled with artificial rearing, may render the neonate unresponsive to
the gut-protective effects of milk oligosaccharides. Whether bovine milk oligosaccharides may affect
other endpoints (e.g., brain functions) in conditions of immaturity remains to be investigated.
Keywords: sialyllactose; oligosaccharides; preterm neonates; milk; gut; microbiota
1. Introduction
Preterm birth is the leading cause of newborn death, and more than one million infants worldwide
die from preterm birth-related complications annually [1]. For the surviving preterm infants, there is
an increased risk for disabilities relative to term infants, and gut immaturity and microbial dysbiosis
(higher stool pH, lower production of short-chain fatty acids (SCFA) and increased number of
pathogens) may contribute to adverse outcomes [2,3]. Mucosal immunity and appropriate bacterial
colonization are key to maintaining gut homeostasis in newborns [4], but little is known about gut
colonization in preterm infants and how it may be modulated by diet. The appearance of beneficial
bacteria, such as bifidobacteria, may be delayed, relative to colonization in term infants, and with
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higher densities of potentially pathogenic bacteria [5–7]. This disturbed colonization pattern may
affect intestinal development in preterm neonates [8].
Breast-fed preterm infants generally have enhanced resistance to infectious diseases and better
cognitive function [9,10], and optimal nutrition via breast milk is key to growth, metabolism,
and immunity of preterm newborns [11]. Early human milk is a rich source of sialic acid bound to
human milk oligosaccharides (HMOs) [12], e.g., sialyllactose (SL), and clinical and preclinical studies
have shown that HMOs, including sialyllated oligosaccharides, pass the small intestine undigested
and are metabolized in the large intestine [13]. HMOs function as the first prebiotics for infants,
but are also suggested to support infant health, growth, and development by acting as antimicrobials,
antiadhesives, and modulators of cell responses [14–16]. Several beneficial effects of sialylated HMOs
related to intestinal function, microbial colonization and immunity in newborns have been documented
in vitro and in pre-clinical animal models [17–20]; for example, the content of disialyllacto-N-tetraose
in the milk has been identified as a potential marker of preterm infants at risk of developing necrotizing
enterocolitis [21].
The recommendation for feeding of preterm infants is mother’s own milk, or alternatively donor
human milk. In cases where neither is available, bovine milk-based formulas are used [22–25],
but addition of HMOs including SL in the formula production is currently not feasible due to lack of
bulk amounts [26]. In germ-free mice and newborn piglets, sialylated bovine milk oligosaccharides
(BMOs) have shown to change the gut microbiota with altered organ metabolism and improved
growth [27]. Similar growth and development was observed in newborn term pigs fed a formula
supplemented with 3’SL or 6’SL for 21 days, but with increased brain ganglioside-bound sialic acid in
corpus callosum and an altered gut microbiota composition [17]. The effects on growth are most likely
related to improved gut metabolism. The 3’SL and 6’SL have been also shown to reduce anxiety-related
parameters in juvenile mice [18]. Here, SL supplementation increased the free-to-bound hippocampal
sialic acid, reduced bound sialic acid in the prefrontal cortex, and increased mean, axial and radial
diffusivity in the corpus callosum in newborn term pigs in a dose-dependent manner, with positive
effects at an intermediate dose of 380 mg SL/L milk replacer [19]. While these studies strongly
suggest brain developmental effects of dietary SL, the gut-brain mechanisms of these maturational
effects remain unknown. Due to a genetic mutation in the human genome, N-glycolylneuraminic
acid (Neu5Gc) cannot be synthesized [28], and hence the sialylated oligosaccharides in human milk
only contains N-acetylneuraminic acid (Neu5Ac). In contrast, sialylated oligosaccharides in bovine
milk are present both as Neu5Gc (approximately 3–6%, [29,30]) and Neu5Ac. Two recent studies
mapping the oligosaccharide composition of porcine milk did not find Neu5Gc in the porcine milk
oligosaccharides [31,32], while a third study identified a single milk oligosaccharide linked to Neu5Gc
in sow’s colostrum, but not in mature sow’s milk [33]. BMOs, such as galacto-oligosaccharides (GOS),
are also considered to have beneficial prebiotic effects in infants and several clinical trials have been
conducted with GOS as a supplement to infant formula. The studies showed overall good tolerability
but limited clinical effects on growth, gastrointestinal infections, respiratory tract infections and
allergic manifestations, but increased stool frequency with a softer stool consistency. Further, changes
in microbiota composition has been observed with the increased number of bifidobacteria [34].
The beneficial effects of milk oligosaccharides (MOs) on gut and immune stimulation, growth
and brain development as observed in normal term animals and infants may be even more important
in sensitive preterm neonates to stimulate gut maturation. However, evidence for beneficial effects
of MOs when the intestine is immature at birth is lacking. Recent studies with complex mixtures of
HMOs (including sialylated HMOs) only observed trends towards reduced necrotizing enterocolitis in
preterm pigs within the first 4–11 days of life, and limited effects on diarrhea, microbial colonization,
gut maturation and immune stimulation [35]. We hypothesized that within a slightly longer period
of 19 days, MOs may benefit gut and immune maturation and improve gut microbial colonization in
preterm neonates. The neonatal pigs share some physiological, anatomical and metabolic characteristics
with human infants [36,37]. Furthermore, the composition of milk oligosaccharides in sow’s milk
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seems to be more comparable to that in human milk than to that in bovine milk [31,32], suggesting
that the preterm pig is a suitable model for investigation of effects related to oligosaccharides,
even bovine based, in newborns. In the present study (Experiment 1), we tested two industrial bovine
milk-based ingredients with improved oligosaccharide content, one enriched with whey-derived
oligosaccharides with sialyllactose (SAL) and the other as a pure enzymatically-derived mix of
heterogeneous oligosaccharides (HOS). Effects on gut maturation, immunity and microbial colonization
within the 19 days were investigated in artificially reared preterm pigs, used as a model for immature
infants. The immature immunity of preterm neonates at birth, together with the artificial rearing
conditions (e.g., rearing in incubators without their mother, and partial parenteral nutrition) may affect
the responsiveness to milk bioactives after birth. Therefore, in an additional experiment (Experiment
2), we evaluated the effects of natural versus artificial rearing by comparing near-term, vaginally born
pigs raised by their sow with corresponding artificially reared, caesarean-delivered pigs.
2. Materials and Methods
2.1. Animal Procedures and Housing
In Experiment 1, 68 pigs derived from three litters were born preterm by cesarean section
at day 106 (corresponding to approximately 90% of full gestation), as previously described [38].
Pigs were stratified according to birth weight and allocated to three groups receiving raw bovine milk
supplemented with either bovine milk oligosaccharide-enriched whey with sialyllactose (PRE-SAL,
n = 22) or an enzymatically-derived mixture of heterogeneous oligosaccharides containing both GOS
and N-acetylglucosamine-linked GOS (GlcNAc-GOS) (PRE-HOS, n = 22). For the control group,
lactose was added to the milk base (PRE-CON, n = 24). Researchers were blinded to treatment groups
throughout the study. Right after birth, the pigs were resuscitated and transferred to oxygenated and
temperature-regulated incubators. Within a few hours after delivery, all pigs were equipped with
a catheter in the umbilical artery to allow parenteral nutrition (PN) and an orogastric tube for enteral
feeding [39]. Within 36 h after birth, all pigs received a total of 25 mL maternal plasma/kg bodyweight
divided into 4 intra-arterial infusions to provide passive immunization. The animal procedures have
previously been described [38]. Each pig was assessed clinically at least twice daily and assigned
a clinical score as described earlier [39]. During the first 11 day, oral antibiotics were given prophylactic
(ampicillin, Norobrittin Vet. 30 mg/kg three times daily and gentamycin, Gentocin Vet., 2.5 mg/kg
twice daily, both ScanVet, Fredensborg, Denmark). On day 2, all pigs received a subcutaneous injection
of iron (Uniferon, 30 mg per pig, Pharmacosmos, Holbæk, Denmark). A total of 99% of the pigs
suffered from various degrees of diarrhea during the study period. Mild cases of diarrhea were
supported with an electrolyte supplement (Revolyt nutrition, Gunnar Kjems, København, Denmark),
while more severe cases of diarrhea were treated with oral antibiotics (ampicillin and gentamycin) for
three consecutive days. In cases with marked clinical affection, additional treatment with systemic
antibiotics (ampicillin, Pentrexyl, 30 mg/kg, Bristol-Myers Squibb, Solna, Sweden and gentamicin,
Hexamycin, 2.5 mg/kg, Sandoz, Copenhagen, Denmark), as well as an addition of metronidazole
(Flagyl, 10 mg/kg, sanofi-aventis, Hørsholm, Denmark) to the oral treatment regime, was initiated.
Eleven pigs were euthanized during the study period due to clinical complications unrelated to the
experimental diets; hence, these data were not included in the analysis. The final group sizes were
PRE-SAL (n = 19), PRE-HOS (n = 18) and PRE-CON (n = 20).
In Experiment 2, one litter of pigs was born on day 112 (e.g., near the anticipated term date of
116–117) by spontaneous vaginal delivery and these pigs were allowed to suckle the sow under natural
rearing conditions in the experimental facility (TERM-NAT, n = 12). Following birth, the near-term
pigs were mobile, thermoregulatory stabile and had a normal ability to suckle their sow (in contrast to
preterm pigs delivered at 90% gestation). These pigs were compared with pigs delivered from a sow
by cesarean section close to term (day 115). The latter pigs were reared under the same conditions as
the preterm pigs in Experiment 1 and fed the same diet (TERM-CON, n = 14).
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2.2. Diets
All experimentally reared pigs (both preterm and near-term) received an enteral base milk diet
supplemented with HOS, SAL or only the control raw bovine milk (CON). All pigs started minimal
enteral nutrition (MEN) at 16 mL/kg/day on the day of birth increasing gradually to 180 mL/kg/day
on day 16. The advancing volumes of enteral nutrition were based on experience from a similar
type of studies in our lab [39] and reflected the upper limit of what was tolerable in the immature
intestine of these preterm pigs. During the first seven days, the pigs were supplemented with PN,
48–144 mL/kg/day (Kabiven modified with Vamin, Soluvit, Vitalipid and Peditrace, all Fresenius
Kabi, Uppsala, Sweden) to meet specific nutrient needs of preterm pigs [38]. During the first five
days, enteral feeding was administered exclusively through the fitted orogastric tubes. From day five
onwards, the pigs were introduced to the milk in drinking troughs and were assisted with the drinking
until they mastered the task on their own. The milk was supplied via the orogastric tube until full
enteral boluses could be consumed voluntarily by each pig. The naturally reared pigs (TERM-NAT)
received the sow’s milk only.
The enteral diet consisted of intact unpasteurized Jersey cow’s milk (protein 38.2 ± 0.35 g/L,
lipid 31.65 ± 1.83 g/L and carbohydrate 44.4 ± 0.44 g/L). After collection from the farm, the milk was
stored in aliquots at −20 ◦C. The HOS blend contained a mixture of GOS and GlcNAc-GOS produced
by trans-galactosylation of bovine milk-based lactose and GlcNAc added as a secondary substrate
(6.7 g/L, Arla Foods Ingredients, Viby, Denmark). The HOS diet was prepared by mixing the HOS
blend as well as lactose (6 g/L, Variolac® 960, Arla Foods Ingredients, Viby, Denmark) with the milk,
to a final dose of 5 g oligosaccharides per liter of milk. The SAL diet was prepared by adding the SAL
blend (8.5 g/L Lacprodan SAL-10®, Arla Foods Ingredients, Viby, Denmark) to the milk, to a final
dose of 380 mg SL per liter of milk. The ingredient contained 4.5% SL with a 6:1 composition of 3’SL
and 6’SL respectively. Additionally, other acidic and neutral bovine milk oligosaccharides from whey
were also present in the product (not quantified). To secure isocaloric diets, 6 g lactose (Variolac® 960,
Arla Foods Ingredients, Viby, Denmark) was added per liter milk of the raw milk in the CON diet.
Milk was prepared on a daily basis and stored at 4 ◦C until use. Aliquots were heated to a maximum
temperature of 40 ◦C prior to feeding.
Verification of the total dosage of SL given in the milk diets, including 3’SL and 6’SL,
were determined using High Performance Anion Exchange Chromatography—Pulsed Amperometric
Detection (HPAEC-PAD). The total levels were 0.433 ± 0.005 mg/mL and 0.120 ± 0.002 mg/mL in the
SAL and CON diets, respectively, with a ratio of 3’SL and 6’SL of 5:1.
2.3. Body Composition and Tissue Collection
On day 19, the pigs were anesthetized with an intramuscular injection of a mixture with
zolazepam/tiletamin (Zoletil 50, Virbac, Kolding, Denmark), xylazine (Xysol, ScanVet, Fredensborg,
Denmark), ketamine (Ketaminol, MSD Animal Health, Copenhagen, Denmark) and butorphanol
(Torbugesic, ScanVet, Fredensborg, Denmark). For each pig, the body composition was determined by
Dual Energy X-ray absorptiometry (DEXA, Lunar Prodigy scanner, GE Healthcare, Little Chalfont,
UK). All scannings were performed in ventral recumbency. Fat and lean mass percentages plus bone
mineral density and bone mineral content were estimated using software provided with the DEXA
scanner. Before euthanasia, blood samples were drawn intracardially. All pigs were euthanized
with an intracardiac injection of sodium pentobarbital (Euthanimal, Scanvet, Fredensborg, Denmark).
Cerebrospinal fluid (CSF) was collected by suboccipital puncture, collected in cryovials and frozen
in liquid nitrogen. Organ weights were measured and intestinal samples (proximal, middle and
distal intestine and colon) were dissected and either frozen in liquid nitrogen or immersed in Clarke’s
solution (absolute alcohol and glacial acetic acid) for fixation before histological preparation. Femurs
from the right hind leg of all the preterm pigs were dissected from the tissue and immersed in
ethanol before aseptic extraction of the bone marrow caput femur for culture. The bone marrow
was homogenized in 1 mL sterile saline using a Stomacher (Seward Ltd., Worthing, UK) and the
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homogenate was plated (1:1, 1:10 and 1:100 v/v dilutions in sterile saline) on tryptic soy agar with 5%
sheep blood, and incubated for 24 h at 37 ◦C. For positive cultures, bacterial isolates would be identified
to the species level by matrix-assisted laser desorption/ionization time-of-flight (Maldi-TOF) mass
spectrometry (Vitek MS RUO, bioMerieux; Craponne, France). All experimental procedures conducted
during the animal experiments were approved by the Danish Animal Experiments Inspectorate (license
number 2014-15-0201-00418), which is in accordance with the guidelines from Directive 2010/63/EU
of the European Parliament and the Animal Research: Reporting of In Vivo Experiments (ARRIVE)
guidelines [40].
2.4. Gut Structure
Villus height and crypt depth were measured by staining with Alcian Blue-Periodic Acid Shiff
(AB-PAS) on Clarke’s fixated samples from the distal part of the small intestine, and the villus-crypt
ratio and colonic goblet cell density was calculated [41]. Pictures were obtained at 200× magnification
by light microscope (Olympus BX45TF, Tokyo, Japan) and a camera with belonging software, cellˆA
(version 3.4, Olympus, Tokyo, Japan). The goblet cell density was calculated as the area fraction
covered by goblet cells relative to the total area covered by tunica mucosa (STEPanizer stereology tool,
version 1.0, STEPanizer, Bern, Germany).
2.5. Gut Function
The digestive capacity for lactose, a surrogate marker of mucosal function, was assessed on days
10 and 19 by an oral administration of a 5% lactose solution (15 mL/kg). The increment in blood
galactose was measured after 40 min from a jugular blood sample [42]. The intestinal permeability was
assessed after an oral administration of a 5% lactulose and 5% mannitol solution 3 h before euthanasia.
At the time of euthanasia, urine was collected by intra-abdominal cystocentesis. The urine was stored at
−20 ◦C until spectrophotometrical analysis [42]. Activities of the brush border disaccharidases, lactase,
maltase, and sucrase, as well as the peptidases, aminopeptidase A (ApA), aminopeptidase N (ApN),
and dipeptidyl peptidase IV (DPPIV), were measured by spectrophotometry of tissue homogenates
originating from the proximal, middle and distal parts of the small intestine [43]. Enzyme activities
were expressed as units per gram of wet tissue.
2.6. Microbiome and Microbial Metabolites
Total DNA was extracted from samples of colon content collected at euthanasia using the
Powersoil DNA isolation kit (MoBio Laboratories, CA, USA) according to the manufacturers
description including an initial bead-beating step using a FastPrep-24™ 5G (MP Biomedicals,
CA, USA). The V3V4 region of the 16S rRNA gene was amplified, sequence adapters and indices were
incorporated, the final amplicon constructs were purified and the library was pooled as previously
lined out [44]. The library was subsequently sequenced by tag-encoded 16S rRNA gene MiSeq-based
(Illumina, CA, USA) high-throughput sequencing as described in detail previously [44]. The raw
dataset was analyzed as previously described [44] to obtain operational taxonomic unit (OTU) tables,
alpha diversity plots (expressed as observed species) and UniFrac Distance metrics principal coordinate
analysis (PCoA) plots for beta diversity. Analysis of similarities (ANOSIM) was used to evaluate group
differences using weighted and unweighted UniFrac analysis. The G test of independence (q_test) was
used for qualitative assessments of the OTUs and analysis of variance (ANOVA) for the quantitative
associations (relative abundance).
Levels of microbial metabolites and short-chain fatty acids, including acetic acid, butyric acid,
propionic acid, valeric acid, propanediol and methyl butanoic acid, were measured in colon content
by gas chromatography–mass spectroscopy and data were presented as µmol/g of wet matter [35].
Lactic acid levels were measured by an injection of 10 µL of supernatant into an Agilent LC/MS
1100 system, equipped with a Repromer H column (250 × 8 mm, 9 µm with matching guard; Maisch,
Ammerbuch, Germany). The mobile phase consisted of isocratic sulfuric acid (5 mmol/L) heated
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to 50 ◦C for columns and detectors with a flow rate of 0.5 mL/min [45]. Quantitation was done by
refractive index detection (RID; Agilent 1260 Infinity II) using lactic acid (Sigma-Aldrich, Taufkirchen,
Germany) as an external standard.
2.7. Hematology, Biochemistry and Systemic Immunity
Heparinized blood, obtained from either cord blood at the cesarean section or by jugular samples
at days 10 and 19, was used for blood cell counting by an automatic cell counter (Advia 2120i
Hematology System, Siemens Healthcare GmbH, Erlangen, Germany). Blood and CSF biochemistry
was analyzed on serum from blood obtained before euthanasia and CSF obtained after euthanasia
(ADVIA 1800 Chemistry System, Siemens Healthcare GmbH, Erlangen, Germany). Immune cell
phagocytosis in preterm and TERM-CON pigs was performed using pHrodo green Staphylococcus
aureus (509/533 nm) BioParticles Phagocytosis Kits (Life Technologies, Taastrup, Denmark) for flow
cytometry [46]. In brief, 100 µL whole blood was challenged with pHrodo Green-conjugated S. aureus
(ratio of particle-to-phagocyte approximately 10:1) at 37 ◦C, 5% CO2 for 30 min. Red blood cells were
then lyzed, and the remaining leukocytes were washed with PBS prior to analysis by FACS Canto II
flow cytometer (BD biosciences, San Jose, CA, USA). Samples without S. aureus challenge served as
controls. The neutrophil population was gated based on forward scatter (FSC) and side scatter (SSC)
dot-plots. Neutrophils with pHrodo+ were identified as neutrophils exerting phagocytic function.
Fluorescence intensity of pHrodo+ population indicated the number of bacteria being phagocytized.
2.8. Statistics
Data were analyzed with the software package R (version 3.3.2, R Foundation for Statistical
Computing, Vienna, Austria), unless otherwise stated, and group comparisons were performed.
Continuous data were analyzed with mixed models adjusting for sex and birth weight as fixed variables
and litter as a random variable. Repeated measurements were analyzed by the lmer function for mixed
modeling as repeated measures. All statistical models were validated by assessment of residuals and
fitted values for normality as well as variance homogeneity. The microbiome data were analyzed as
previously described, including false discovery rate (FDR) correction [44]. Genera accounting for >1%
of the total relative abundance were presented graphically. p < 0.05 was chosen as the critical level of
significance. Data were presented as raw arithmetic means and SD, unless otherwise stated. For data
interpretation, the preterm intervention groups, PRE-SAL and PRE-HOS, were compared with the
preterm control group (PRE-CON). Rearing conditions were compared by comparing TERM-CON
with TERM-NAT.
3. Results
3.1. Experiment 1
3.1.1. Clinical Condition, Body Growth and Composition
Birth weight and body weight gain were similar across PRE-CON, PRE-HOS and PRE-SAL,
with an average birth weight of 896 ± 196 g, and an average body weight gain of ~24 g/kg/day across
the groups (Figure 1). Further, they had similar bone mass density and bone mineral content on day 19
as well as equal fat and lean mass percentages (Figure S1, Supplementary Materials).
There were episodes of diarrhea among PRE-CON, PRE-HOS and PRE-SAL with a mean of
8.7 days with diarrhea for all groups. Particularly, one of the three litters of preterm pigs showed
marked diarrhea and was severely clinically affected (on average 13.3 days with diarrhea relative to 6.7
and 6.8 days for the other two litters). This litter was treated systemically with additional antibiotics
and received increased volumes and 5-day extension of the PN support to ensure survival of the pigs.
Bone marrow homogenates collected on day 19 from all preterm animals were sterile, indicating that
no pigs had blood stream infection at this time point. Relative to PRE-CON, the PRE-SAL had lower
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relative weights of the adrenal glands (p < 0.05), whereas the relative weights of other organs did not
differ among the preterm groups (Table S1, Supplementary Materials).Nutrients 2018, 10, x FOR PEER REVIEW  7 of 18 
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respectively, across groups). Similarly, the intestinal permeability measured by the lactulose-to-
mannitol ratio on day 19 was equal among the groups (0.50 ± 0.56 across groups), as well as the 
activity of the six different brush border enzymes in the proximal and distal part of the small intestine. 
In the middle part of the small intestine, PRE-SAL had decreased maltase activity relative to PRE-
CON (p < 0.05, Figure 2). 
 
Figure 2. Small intestinal brush border enzyme activities in preterm pigs (Experiment 1). (A) Sucrase, 
(B) maltase, (C) lactase, (D) aminopeptidase N, (E) aminopeptidase A and (F) dipeptidyl peptidase 
IV. All were measured in the middle part of the small intestine. Values are presented as mean ± SEM. 
The * indicate statistical significant difference between groups of p < 0.05. 
Figure 1. Growth curves in preterm pigs (Experim nt 1). Daily weights of preterm pigs with or without
oligosaccharide supplementations. No differences were observed between PRE-CON (white) and
the supplemented groups, PRE-HOS (light grey) and PRE-SAL (dark grey). Values are presented as
mean ± standard error of the mean (SEM).
3.1.2. Gut Structure and Function
No differences were observed among the preterm groups for villus and crypt lengths as
well as villus–crypt ratios, and the goblet cell density was simila between the three groups
(Figure S2, Supplementary Materials). T e increment in plasma galact se after an oral lactose bolus
given on days 10 and 19 did not differ between the three preterm groups (61 ± 60 µmol/L and
101 ± 164 µmol/L, respectively, across groups). Similarly, the intestinal permeability measured by the
lactulose-to-mannitol ratio on day 19 was equal among the groups (0.50 ± 0.56 across groups), as well
as the activity of the six different brush border enzymes in the proximal and distal part of the small
intestine. In the middle part of the small intestine, PRE-SAL had decreased maltase activity relative to
PRE-CON (p < 0.05, Figure 2).
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Figure 2. Small intesti al brush border enzyme a ti ities in pr term pigs (Exp riment 1). (A) Sucrase,
(B) maltase, (C) lactase, (D) aminopeptidase N, (E) aminopeptidase A and (F) dipeptidyl peptidase
IV. All were measured in the middle part of the small intestine. Values are presented as mean ± SEM.
The * indicate statistical significant difference between groups of p < 0.05.
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3.1.3. Gut Microbiota and Microbial Metabolites
For the gut microbiota analyses by 16S rRNA gene amplicon sequencing, five samples out of
a total of 88 samples were excluded due to low sample reads (<25,000 reads per sample). The colonic
microbial diversity at day 19, as indicated by the number of bacterial OTUs, was not influenced by the
different feeding protocols in the preterm pigs. The majority of sample reads (>99%) were distributed
within five different phyla, with Proteobacteria (mainly represented by family Enterobacteriaceae) and
Firmicutes (with Lactobacillus spp. and Enterococcus spp. among the dominating species, together with
members of the family Lachnospiraceae) dominating the gut microbiota (Figure 3A). No differences
among the preterm groups were observed for the number of observed species (Figure 3B). Neither was
the colonic microbiota composition influenced by the different feeding protocols, as determined by
both weighted as well as unweighted UniFrac distance dissimilarity metrics (results not shown).
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Figure 3. Microbiology in preterm pigs (Experi ent 1). (A) Relative microbial abundance in colon for
each pr term pig as determined by 16S rRNA ge plicon seque cing. (B) Microbial diversity in
colon of preterm pigs shown by the number of observed species. No differences were observed between
PRE-CON (white) and the supplemented groups, PRE-HOS (light grey) and PRE-SAL (dark grey),
respectively. Values are presented as mean ± SD.
The levels of the microbial metabolites, acetic acid, butyric acid, propionic acid, valeric acid,
propanediol, methyl butanoic acid and lactate were all similar between PRE-CON, PRE-HOS and
PRE-SAL (Figure 4).
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(A) Acetic acid, (B) propionic acid, (C) butyric acid, (D) valeric acid, (E) propanediol, (F) methyl
butanoic acid, (G) lactate (hydroxy propanoic acid) and (H) sum of all microbial metabolites including
lactate (Σ(SCFA)). Values are presented as mean ± SEM.
3.1.4. Hematology, Biochemistry and Systemic Immunity
Blood cell counts on days 1, 10 and 19 are listed in Table S2 (Supplementary Materials). Apart from
PRE-SAL, which had higher platelet counts at birth relative to PRE-CON (p < 0.05), no differences
were observed between the three preterm groups. Serum biochemistry on day 19 showed increased
values of alkaline phosphatase and glucose along with lower values of aspartate aminotransferase in
PRE-HOS, relative to those in PRE-CON (all p < 0.05, Table 1). No differences in serum biochemistry
parameters were observed between PRE-CON and PRE-SAL, whereas the CSF biochemistry showed
higher values of glucose for PRE-HOS compared with those for PRE-CON (p < 0.05).
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Table 1. Serum and CSF biochemistry measured at day 19 in preterm pigs (Experiment 1).
Serum PRE-CON PRE-HOS PRE-SAL
Albumin (g/L) 15.62 ± 2.14 15.62 ± 3.01 16.24 ± 3.32
Total protein (g/L) 26.93 ± 2.95 27.13 ± 4.82 26.96 ± 4.52
Alkaline phosphatase (U/L) 728.9 ± 298.8 974.7 ± 454.7 ∆ 763.6 ± 284.7
Alanine aminotransferase (U/L) 28.85 ± 7.42 25.72 ± 5.80 25.78 ± 5.43
Total bilirubin (µmol/L) 2.15 ± 1.93 1.74 ± 0.99 1.98 ± 1.16
Cholesterol (mmol/L) 2.35 ± 0.46 2.42 ± 0.42 2.30 ± 0.56
Creatinine (µmol/L) 63.35 ± 34.37 59.56 ± 14.30 59.67 ± 30.64
Creatine kinase (U/L) 138.4 ± 85.0 123.9 ± 39.3 140.8 ± 76.5
Iron (µmol/L) 11.52 ± 3.96 12.74 ± 6.05 11.32 ± 5.65
Phosphate (mmol/L) 2.36 ± 0.43 2.22 ± 0.40 2.33 ± 0.38
Aspartate aminotransferase (U/L) 35.05 ± 19.09 26.67 ± 6.15 ∆ 29.78 ± 5.43
Blood urea nitrogen (mmol/L) 8.74 ± 5.37 6.86 ± 4.30 6.23 ± 4.91
Gamma-glutamyl transferase (U/L) 26.05 ± 6.13 23.78 ± 11.24 21.94 ± 8.43
Calcium (mmol/L) 2.37 ± 0.25 2.44 ± 0.23 2.37 ± 0.24
Magnesium (mmol/L) 0.81 ± 0.13 0.86 ± 0.16 0.86 ± 0.15
Sodium (mmol/L) 140.4 ± 6.8 140.8 ± 8.0 139.0 ± 10.1
Potassium (mmol/L) 3.71 ± 0.67 3.82 ± 0.41 3.84 ± 0.47
Lactate (mmol/L) 1.56 ± 0.96 2.26 ± 2.38 2.27 ± 1.60
Glucose (mmol/L) 4.18 ± 1.58 5.32 ± 2.48 ∆ 5.17 ± 2.77
CSF
Albumin (mg/L) 12.89 ± 3.71 19.60 ± 26.11 18.57 ± 13.32
Total protein (mg/L) 177.3 ± 51.2 294.0 ± 455.1 260.0 ± 217.9
Lactate (mmol/L) 1.71 ± 0.78 1.86 ± 0.56 1.82 ± 0.66
Glucose (mmol/L) 2.28 ± 0.97 2.78 ± 0.70 ∆ 2.74 ± 1.30
Abbreviations: CSF, cerebrospinal fluid. ∆ indicates a difference between PRE-CON and PRE-HOS. Values are
presented as mean ± SD.
PRE-CON, PRE-HOS and PRE-SAL had similar proportions of neutrophils with phagocytic
capacity of S. aureus as measured in cord blood at day 1, and the phagocytic capacity increased after
birth in a similar manner between the groups (Figure 5A). At day 19, the number of engulfed S. aureus
in PRE-HOS was higher relative to PRE-CON pigs (p < 0.05, Figure 5B).
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Figure 5. Phagocytic activity in preterm pigs (Experiment 1). (A) Proportion of neutrophils exerting
phagocytosis against Staphylococcus aureus and (B) total number of engulfed S. aureus by neutrophils.
Values are presented as mean ± SEM. The * indicate stati l sign ficant difference b tween groups of
p < 0.05.
3.2. Experiment 2
3.2.1. Clinical Condition, Body Growth and Composition
The naturally reared TERM-NAT were weighted on day 3 after birth, with a mean body weight
of 1298 ± 311 g, which was higher than the artificially reared TERM-CON on day 3 (1133 ± 166 g,
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p < 0.001), and had a higher average weight gain (~64 g/kg/day) relative to TERM-CON (~22 g/kg/day,
p < 0.001). The TERM-CON had an average of 6.4 days with diarrhea, whereas TERM-NAT
had no clinical complications during the study period. The bone mass density was lower in
TERM-CON compared to TERM-NAT (0.201 ± 0.016 g/cm2 vs. 0.244 ± 0.042 g/cm2, p < 0.05).
In contrast, the relative bone mineral content and lean mass percentage were higher in TERM-CON
(17.7 ± 1.48 g/kg and 94.1 ± 7.37%) relative to TERM-NAT (15.0 ± 1.04 g/kg and 88.9 ± 6.06%,
p < 0.001 and 0.01, respectively). The fat percentage was lower in TERM-CON (2.71 ± 1.17%) relative
to TERM-NAT (8.56 ± 5.13%, p < 0.01). The relative weights of the proximal small intestine, colon,
adrenals and brain were higher in TERM-CON relative to TERM-NAT pigs, while the weights of the
middle part of the small intestine, spleen and lungs were lower (Table S3, Supplementary Materials).
3.2.2. Gut Structure and Function
TERM-CON had shorter crypts and villi relative to TERM-NAT (p < 0.01), as well as a lower
villus–crypt ratio (6.88 ± 2.76 vs. 16.0 ± 4.69, p < 0.001). The goblet cell density was increased
(11.8 ± 4.56%) relative to TERM-NAT (6.81 ± 3.27%, p < 0.01). The intestinal permeability was equal
among the two near-term groups (lactulose mannitol ratio of 0.55 ± 1.05 in both groups), whereas
TERM-CON had decreased enzyme capacities for all measured enzymes relative to TERM-NAT
(71.2–97.2% decrease, all p < 0.001, Table S4, Supplementary Materials).
3.2.3. Gut Microbiota and Microbial Metabolites
The number of observed species was higher in TERM-NAT (p = 0.001, Figure 6A) compared
to TERM-CON, and they were dominated by Firmicutes (mainly members of the Ruminococcaceae
family), Bacteroidetes (mainly represented by the Bacteroides and Prevotella genera) and the phylum
Spirochaetes (<5%) (Figure 6B), whereas TERM-CON pigs were distributed similarly to the preterm
pigs in Experiment 1, raised in the same artificial environment. The colonic microbiota composition
of TERM-NAT was different from that of TERM-CON, as determined by both weighted as well as
unweighted UniFrac distance dissimilarity metrics (p < 0.001, results not shown). Lactate levels were
higher in TERM-CON (849% higher, p < 0.01), but levels of the other microbial metabolites measured,
except for propanediol, were lower relative to TERM-NAT pigs (52–98% lower, p < 0.01, Table S4,
Supplementary Materials). The total amount of microbial metabolites measured tended to be lower in
TERM-CON relative to in TERM-NAT (p = 0.053, Table S4, Supplementary Materials).
3.2.4. Hematology, Biochemistry and Systemic Immunity
The capacity of neutrophils to engulf S. aureus was 2.6-fold higher than the preterm pigs in
Experiment 1, indicating that the systemic immunity in TERM-CON pigs at birth was more mature.
At day 10, TERM-CON showed lower counts of platelets and white blood cells (WBC), including
neutrophils, lymphocytes and monocytes relative to TERM-NAT, but had higher counts of red blood
cells and basophils as well as an increased level of haemoglobin. At day 19, TERM-CON further
showed an increased hematocrit relative to TERM-NAT (p < 0.01, Table S5, Supplementary Materials).
Many serum biochemistry markers (e.g., albumin, creatinine and cholesterol) differed between the
TERM-CON and TERM-NAT, and the CSF biochemistry showed lower values of both albumin and
total protein in TERM-CON relative to TERM-NAT (p < 0.01, Table S6, Supplementary Materials).
Nutrients 2018, 10, 1489 12 of 18
Nutrients 2018, 10, x FOR PEER REVIEW  12 of 18 
 
 
Figure 6. Microbiology in near-term pigs (Experiment 2). (A) Microbial diversity in colon of near-term 
pigs shown by the number of observed species. (B) Relative microbial abundance in colon for each 
near-term pig as determined by 16S rRNA gene amplicon sequencing. Values are presented as mean 
± SD. The *** indicate statistical significant difference between groups of p < 0.001. 
4. Discussion 
Enteral feeding is key to proper organ development, particularly in preterm neonates. Due to 
the presumed beneficial effects of MOs, the addition of bovine milk-based oligosaccharide-enriched 
whey to the milk diet within the first weeks of life could potentially be beneficial for preterm 
newborns that do not receive human milk, by stimulating immune and microbial parameters. 
Optimally, when human milk is not available, oligosaccharide structures, similar to the ones found 
in human milk, should be added to infant formula to simulate the human milk patterns. Ddue to the 
high species variation and low production capacity this has so far been difficult. While sialic acid in 
Figure 6. Microbiology in near-term pigs (Experiment 2). (A) Microbial diversity in colon of near-term
pigs shown by the number of observed species. (B) Relative microbial abundance in colon for
each near-term pig as determined by 16S rRNA gene amplicon sequencing. Values are presented
as mean ± SD. The *** indicate statistical significant difference between groups of p < 0.001.
4. Discussion
En eral feeding is key to proper organ development, particularly in preterm neonates. Due to the
presumed beneficial effects of MOs, the addition of bovine milk-based oligosaccharide-enriched whey
to the milk diet within the first weeks of life could potentially be beneficial for preterm newborns that
do not receive human milk, by stimulating immune and microbial parameters. Optimally, when human
milk is not available, oligosaccharide structures, similar to the ones found in human milk, should
be added to infant formula to simulate the human milk patterns. Ddue to the high species variation
and low production capacity this has so far been difficult. While sialic acid in human milk is mainly
bound to oligosaccharides, cow’s milk-based infant formula has the majority of sialic acid bound to
glycoproteins [26]. Limited research has investigated effects of oral administration of sialic acid or SL in
preterm neonates. We hypothesized that a bovine milk-based ingredient enriched in oligosaccharides,
including SL in levels similar to that of mature human milk, would benefit several gut and immune
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maturation parameters. Similarly, an oligosaccharide ingredient produced enzymatically from bovine
lactose and GlcNAc represents a slightly more complex mixture of heterogeneous oligosaccharides as
compared to BMOs.
In this study, we showed that pigs fed SAL and HOS tolerated the experimental diets with no
additional adverse effects relative to PRE-CON. The tolerability is in agreement with the literature
within this field [17,47–50]. PRE-SAL pigs, which received oligosaccharides with SL in levels equal
to the natural content of 330–880 mg/L in human breast milk [51–53], in general, did not differ in
parameters related to growth, organ weights, microbiota, functional gut parameters and immunity
compared to PRE-CON. This is in line with earlier studies. In rats, a subchronic toxicity study with
oral administration of a synthetically produced sialic acid showed small negative changes in body
weight, but overall, no signs of adverse effects due to administration of sialic acid were observed [47].
Similar growth curves were observed for PRE-SAL, PRE-HOS and PRE-CON, and analysis of the
body composition after DEXA scans did not reveal any differences among the three preterm groups.
Values on day 19, for both the bone mineral content, lean mass and fat percentage, are comparable
with results from 26-day-old preterm pigs [39]. The difference in platelet counts between PRE-CON
and PRE-SAL was only seen on day 1 and was a coincidental result from the stratification and not
diet-related. All three preterm groups had similar gut structural values for both the crypt and villus
measures in the distal small intestine as well as the goblet cell density in the colon. Among the brush
border enzymes, only PRE-SAL had lower activity of maltase relative to PRE-CON in the middle
part of the small intestine. Since no other gastrointestinal changes were observed, we considered
this an occasional finding. Brush border enzyme activities in the present study were similar to the
levels measured in a previous study with preterm pigs reared for 26 days [54]. All groups showed
similar functional gut properties with regard to absorptive capacity and intestinal permeability with
no additional effects of the bovine milk oligosaccharides.
The main effects of oligosaccharides in the neonatal gut have been related to modulation of the
microbiota as well as their fermentation products by either direct or indirect effects [55]. The microbiota
analysis of colon content in the pigs on day 19 revealed a similar overall pattern across all three preterm
groups. Collectively, the relative abundance as well as similar alpha and beta diversity suggested
that addition of oligosaccharide-enriched whey did not have additional effects on the bacterial gut
microbiota in this study. This is in contrast to an earlier study where changes in the colonic microbiota
were observed [17]. Further, no differences in species richness or overall patterns of OTUs were
observed between PRE-CON, PRE-SAL or PRE-HOS. Due to the occurrence of diarrhea in many
of the pigs, they were treated with antibiotics. Administration of antibiotics in early life to preterm
infants has profound impact on the microbiota, including decreased diversity and lowered colonization
beneficial bacteria, such as Bifidobacterium, while potentially undesirable taxa, such as Enterococcus,
increase [56]. Thus, the antibiotics treatment may possibly have surpassed any potential positive
influence of the supplemented oligosaccharides on the microbiota. Further, the levels of microbial
metabolites were similar among all three preterm groups, suggesting an unaltered fermentation pattern
after oligosaccharide supplementation. The production of SCFAs depends on both the species and
the number of bacteria present in the colon [57], as well as substrate availability. The antibiotics
treatment administered during the artificial rearing and the immature gut epithelium is possibly
determining the microbiota and thereby the amount of SCFAs [58–60]. The relatively short exposure
time (19 days) to the MOs may be too short to produce detectable differences between the preterm
groups, although it represents most of the milk feeding period of pigs. The SL presented as Neu5Gc in
bovine milk is only present in limited amounts in porcine milk [31–33], but is found in pork meat [26,61].
Even though Neu5Gc content is minor in porcine milk and not present in human milk, it may serve
similar activity related to the external gut environment, such as the microbiota, which remains more
universal across species.
Relative to the preterm pigs, the TERM-CON had a higher proportion of neutrophils with
phagocytotic capacity both at birth and day 19. This observation confirmed that the systemic innate
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immunity of the preterm pigs was immature relative to their near-term born counterparts [4], making
them more susceptible to infections.
As a consequence of preterm birth, the lacking organ maturity and abnormal microbial
colonization puts the infant at higher risk of adverse outcomes [2,3]. TERM-CON was born with
a higher birth weight relative to their preterm counterparts, and the higher body weight remained
consistent throughout the study period, although similar growth rates were observed for the preterm
and near-term pigs. Both the preterm pigs and TERM-CON suffered from diarrhea during the
study period, but surprisingly, the extent and clinical consequences were more profound in the
TERM-CON group. Compared with other studies of term pigs born and reared in our lab in an identical
manner [39], the clinical complications and low growth rates observed in the present study may reflect
that the TERM-CON litter was particularly compromised. The TERM-CON further had lower fat
percentages, reflecting emaciation, but higher bone mineral densities compared with the preterm
pigs. In comparison, the near-term pigs born by vaginal birth, and kept and nourished by the sow
(TERM-NAT) had markedly higher weight gain and no diarrhea. DEXA scans revealed both lowered
bone mineral densities as well as a decreased fat percentage for TERM-CON relative to TERM-NAT.
The differences in gut functions further substantiate the general difference between TERM-CON
and TERM-NAT, as TERM-CON showed both decreased villus length and crypt depths in the small
intestine as well as a marked higher goblet cell density in colon. This was also reflected on the functional
side, where TERM-CON had decreased activities of all six brush border enzymes compared with
TERM-NAT. As expected, many environmental factors (delivery mode, rearing conditions, medication
and nutrition) lead to different microbiota composition as well as changes in the concentration of
microbial metabolites. TERM-NAT showed a higher diversity and increased levels of microbial
metabolites, other than lactate, compared to TERM-CON. This reflects a mature and fully functional
anaerobe flora with a lower degree of facultative anaerobes and less Lactobacillus spp.
These results implied that environmental factors have a major influence on early life development,
and although it is not possible to strictly differentiate between litter effects and environmental effects,
the profound difference between the two rearing conditions was demonstrated. The TERM-NAT
group showed the physiological potential of near-term pigs when rearing conditions were optimal.
In contrast, the TERM-CON group delineated the neonatal responses of artificial rearing conditions
identical to the three preterm groups, which may pose a stronger mark on development of the neonate
than optimized nutrition can influence.
5. Conclusions
In conclusion, supplementation of bovine milk-based oligosaccharide ingredients did not improve
gut and immune endpoints in preterm pigs during the milk feeding period. The artificial rearing
conditions of preterm pigs in incubators led to clinical complications, and the supplements did not
reduce or increase the clinical symptoms. The changes in growth, body composition and gut function
were more affected by the mode of delivery and artificial rearing rather than by gestational age at
birth. Potential beneficial effects of oligosaccharide-rich bovine milk supplements on gut and immune
functions may be less effective following preterm birth and artificial rearing, compared with more
natural conditions. The effects on other endpoints, such as brain functions, in conditions of immaturity,
remain to be investigated.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/10/10/
1489/s1, Figure S1: Dual Energy X-ray absorptiometry (DEXA) (Experiment 1), Figure S2: Gut structure
(Experiment 1), Table S1: Organ weights (Experiment 1), Table S2: Hematology (Experiment 1), Table S3: Organ
weights (Experiment 2), Table S4: Small intestinal brush border enzyme activity and colonic microbial metabolite
concentrations (Experiment 2), Table S5: Hematology (Experiment 2), Table S6: Serum and CSF biochemistry
(Experiment 2).
Author Contributions: Conceptualizing and planning of the study, K.O.-R., A.B.H., M.C., P.T.S., T.T., and S.B.B.;
conducting the study, K.O.-R., D.N.N., A.B.B., T.T., and S.B.B.; data analysis and interpretation, K.O.-R., A.K.R.,
D.N.N., S.R., A.B.B., D.S.N., M.C., P.T.S, T.T., and S.B.B.; writing of the original draft preparation, K.O.-R., P.T.S.,
Nutrients 2018, 10, 1489 15 of 18
T.T., and S.B.B.; writing of review and editing, K.O.-R., A.K.R., D.N.N., S.R., A.B.B., D.S.N., A.B.H, M.C., P.T.S., T.T.
and S.B.B.; project administration, P.T.S. and S.B.B.; funding acquisition, P.T.S.
Funding: Arla Foods Ingredients and the Innovation Fund Denmark (NEOMUNE grant number 0603-00774B)
funded this research.
Acknowledgments: The authors thank Jane Povlsen, Martin Peter Rydal, Elin Skytte, Svend Erik Ramskov Garbus
and Kristina Møller, University of Copenhagen for assistance with animal procedures and laboratory analyses.
We greatly appreciate the dietary SL analyses made by Gregers Hendrik Hansen, Arla Foods Ingredients and raw
milk analysis made by Anni Bygvrå Hougaard, Department of Food Science, University of Copenhagen.
Conflicts of Interest: The author Anne Birgitte Heckmann is employed at Arla Foods Ingredients and the author
Maciej Chichlowski is employed at the Mead Johnson Pediatric Nutrition Institute. The other authors declare no
conflict of interest.
References
1. Kumar, R.K.; Singhal, A.; Vaidya, U.; Banerjee, S.; Anwar, F.; Rao, S. Optimizing Nutrition in Preterm Low
Birth Weight Infants—Consensus Summary. Front. Nutr. 2017, 4, 20. [CrossRef] [PubMed]
2. Morowitz, M.J.; Poroyko, V.; Caplan, M.; Alverdy, J.; Liu, D.C. Redefining the Role of Intestinal Microbes in
the Pathogenesis of Necrotizing Enterocolitis. Pediatrics 2010, 125, 777–785. [CrossRef] [PubMed]
3. Van Saene, H.K.F.; Taylor, N.; Donnell, S.C.; Glynn, J.; Magnall, V.L.; Okada, Y.; Klein, N.J.; Pierro, A.;
Lloyd, D.A. Gut overgrowth with abnormal flora: The missing link in parenteral nutrition-related sepsis in
surgical neonates. Eur. J. Clin. Nutr. 2003, 57, 548–553. [CrossRef] [PubMed]
4. Hodzic, Z.; Bolock, A.M.; Good, M. The Role of Mucosal Immunity in the Pathogenesis of Necrotizing
Enterocolitis. Front. Pediatr. 2017, 5, 40. [CrossRef] [PubMed]
5. Westerbeek, E.; van den Berg, A.; Lafeber, H.; Knol, J.; Fetter, W.; van Elburg, R. The intestinal bacterial
colonisation in preterm infants: A review of the literature. Clin. Nutr. 2006, 25, 361–368. [CrossRef] [PubMed]
6. Magne, F.; Suau, A.; Pochart, P.; Desjeux, J.-F. Fecal microbial community in preterm infants.
J. Pediatr. Gastroenterol. Nutr. 2005, 41, 386–392. [CrossRef] [PubMed]
7. Underwood, M.A.; German, J.B.; Lebrilla, C.B.; Mills, D.A. Bifidobacterium longum subspecies infantis:
Champion colonizer of the infant gut. Pediatr. Res. 2015, 77, 229–235. [CrossRef] [PubMed]
8. Butel, M.-J.; Suau, A.; Campeotto, F.; Magne, F.; Aires, J.; Ferraris, L.; Kalach, N.; Leroux, B.; Dupont, C.
Conditions of bifidobacterial colonization in preterm infants: A prospective analysis. J. Pediatr. Gastroenterol.
Nutr. 2007, 44, 577–582. [CrossRef] [PubMed]
9. Lawrence, R.M.; Pane, C.A. Human Breast Milk: Current Concepts of Immunology and Infectious Diseases.
Curr. Probl. Pediatr. Adolesc. Health Care 2007, 37, 7–36. [CrossRef] [PubMed]
10. Smith, M.M.; Durkin, M.; Hinton, V.J.; Bellinger, D.; Kuhn, L. Influence of Breastfeeding on Cognitive Outcomes at
Age 6-8 Years: Follow-up of Very Low Birth Weight Infants. Am. J. Epidemiol. 2003, 158, 1075–1082. [CrossRef]
[PubMed]
11. Donovan, R.; Puppala, B.; Angst, D.; Coyle, B.W. Outcomes of early nutrition support in extremely
low-birth-weight infants. Nutr. Clin. Pract. 2006, 21, 395–400. [CrossRef] [PubMed]
12. Wang, B.; Brand-Miller, J.; McVeagh, P.; Petocz, P. Concentration and distribution of sialic acid in human
milk and infant formulas. Am. J. Clin. Nutr. 2001, 74, 510–515. [CrossRef] [PubMed]
13. Chaturvedi, P.; Warren, C.D.; Buescher, C.R.; Pickering, L.K.; Newburg, D.S. Survival of human milk
oligosaccharides in the intestine of infants. Adv. Exp. Med. Biol. 2001, 501, 315–323. [PubMed]
14. Moukarzel, S.; Bode, L. Human Milk Oligosaccharides and the Preterm Infant: A Journey in Sickness and in
Health. Clin. Perinatol. 2017, 44, 193–207. [CrossRef] [PubMed]
15. Bode, L. Human milk oligosaccharides: Prebiotics and beyond. Nutr. Rev. 2009, 67, 183–191. [CrossRef]
[PubMed]
16. Niñonuevo, M.R.; Lebrilla, C.B. Mass spectrometric methods for analysis of oligosaccharides in human milk.
Nutr. Rev. 2009, 67, S216–S226. [CrossRef] [PubMed]
17. Jacobi, S.K.; Yatsunenko, T.; Li, D.; Dasgupta, S.; Yu, R.K.; Berg, B.M.; Chichlowski, M.; Odle, J. Dietary
Isomers of Sialyllactose Increase Ganglioside Sialic Acid Concentrations in the Corpus Callosum and
Cerebellum and Modulate the Colonic Microbiota of Formula-Fed Piglets. J. Nutr. 2016, 146, 200–208.
[CrossRef] [PubMed]
Nutrients 2018, 10, 1489 16 of 18
18. Tarr, A.J.; Galley, J.D.; Fisher, S.E.; Chichlowski, M.; Berg, B.M.; Bailey, M.T. The prebiotics 3′Sialyllactose and
6′Sialyllactose diminish stressor-induced anxiety-like behavior and colonic microbiota alterations: Evidence
for effects on the gut-brain axis. Brain Behav. Immun. 2015, 50, 166–177. [CrossRef] [PubMed]
19. Mudd, A.; Fleming, S.; Labhart, B.; Chichlowski, M.; Berg, B.; Donovan, S.; Dilger, R. Dietary Sialyllactose
Influences Sialic Acid Concentrations in the Prefrontal Cortex and Magnetic Resonance Imaging Measures
in Corpus Callosum of Young Pigs. Nutrients 2017, 9, 1297. [CrossRef] [PubMed]
20. Yu, Z.T.; Chen, C.; Newburg, D.S. Utilization of major fucosylated and sialylated human milk
oligosaccharides by isolated human gut microbes. Glycobiology 2013, 23, 1281–1292. [CrossRef] [PubMed]
21. Autran, C.A.; Kellman, B.P.; Kim, J.H.; Asztalos, E.; Blood, A.B.; Spence, E.C.H.; Patel, A.L.; Hou, J.;
Lewis, N.E.; Bode, L. Human milk oligosaccharide composition predicts risk of necrotising enterocolitis in
preterm infants. Gut 2018, 67, 1064–1070. [CrossRef] [PubMed]
22. Klingenberg, C.; Embleton, N.D.; Jacobs, S.E.; O’Connell, L.A.F.; Kuschel, C.A. Enteral feeding practices
in very preterm infants: An international survey. Arch. Dis. Child. Fetal Neonatal Ed. 2012, 97, F56–F61.
[CrossRef] [PubMed]
23. American Academy of Pediatrics. Breastfeeding and the use of human milk. Pediatrics 2012, 129, e827–e841.
[CrossRef] [PubMed]
24. Martín-Sosa, S.; Martín, M.-J.; García-Pardo, L.-A.; Hueso, P. Sialyloligosaccharides in Human and Bovine
Milk and in Infant Formulas: Variations with the Progression of Lactation. J. Dairy Sci. 2003, 86, 52–59.
[CrossRef]
25. Quigley, M.; Embleton, N.D.; McGuire, W. Formula versus donor breast milk for feeding preterm or low
birth weight infants. Cochrane Database Syst. Rev. 2018, 6, CD002971. [CrossRef] [PubMed]
26. Wang, B. Sialic Acid Is an Essential Nutrient for Brain Development and Cognition. Annu. Rev. Nutr.
2009, 29, 177–222. [CrossRef] [PubMed]
27. Charbonneau, M.R.; O’Donnell, D.; Blanton, L.V.; Totten, S.M.; Davis, J.C.C.; Barratt, M.J.; Cheng, J.;
Guruge, J.; Talcott, M.; Bain, J.R.; et al. Sialylated Milk Oligosaccharides Promote Microbiota-Dependent
Growth in Models of Infant Undernutrition. Cell 2016, 164, 859–871. [CrossRef] [PubMed]
28. Hedlund, M.; Tangvoranuntakul, P.; Takematsu, H.; Long, J.M.; Housley, G.D.; Kozutsumi, Y.; Suzuki, A.;
Wynshaw-Boris, A.; Ryan, A.F.; Gallo, R.L.; et al. N-glycolylneuraminic acid deficiency in mice: Implications
for human biology and evolution. Mol. Cell. Biol. 2007, 27, 4340–4346. [CrossRef] [PubMed]
29. Puente, R.; Hueso, P. Lactational changes in the N-glycoloylneuraminic acid content of bovine milk
gangliosides. Biol. Chem. Hoppe Seyler 1993, 374, 475–478. [CrossRef] [PubMed]
30. Tangvoranuntakul, P.; Gagneux, P.; Diaz, S.; Bardor, M.; Varki, N.; Varki, A.; Muchmore, E. Human
uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proc. Natl. Acad. Sci. USA
2003, 100, 12045–12050. [CrossRef] [PubMed]
31. Difilippo, E.; Pan, F.; Logtenberg, M.; Willems, R.; Braber, S.; Fink-Gremmels, J.; Schols, H.A.; Gruppen, H.
Milk oligosaccharide variation in sow milk and their fermentation in piglet intestine. J. Agric. Food Chem.
2016, 64, 2087–2093. [CrossRef] [PubMed]
32. Mudd, A.T.; Salcedo, J.; Alexander, L.S.; Johnson, S.K.; Getty, C.M.; Chichlowski, M.; Berg, B.M.; Barile, D.;
Dilger, R.N. Porcine Milk Oligosaccharides and Sialic Acid Concentrations Vary Throughout Lactation.
Front. Nutr. 2016, 3. [CrossRef] [PubMed]
33. Tao, N.; Ochonicky, K.L.; German, J.B.; Donovan, S.M.; Lebrilla, C.B. Structural determination and daily
variations of porcine milk oligosaccharides. J. Agric. Food Chem. 2010, 58, 4653–4659. [CrossRef] [PubMed]
34. Skórka, A.; Pies´cik-Lech, M.; Kołodziej, M.; Szajewska, H. Infant formulae supplemented with prebiotics: Are they
better than unsupplemented formulae? An updated systematic review. Br. J. Nutr. 2018, 119, 810–825. [CrossRef]
[PubMed]
35. Rasmussen, S.O.; Martin, L.; Østergaard, M.V.; Rudloff, S.; Roggenbuck, M.; Nguyen, D.N.; Sangild, P.T.;
Bering, S.B. Human milk oligosaccharide effects on intestinal function and inflammation after preterm birth
in pigs. J. Nutr. Biochem. 2016, 40, 141–154. [CrossRef] [PubMed]
36. Puiman, P.J.; Stoll, B. Animal models to study neonatal nutrition in humans. Curr. Opin. Clin. Nutr. Metab. Care
2008, 11, 601–606. [CrossRef] [PubMed]
37. Moughan, P.J.; Birtles, M.J.; Cranwell, P.D.; Smith, W.C.; Pedraza, M. The piglet as a model animal
for studying aspects of digestion and absorption in milk-fed human infants. World Rev. Nutr. Diet.
1992, 67, 40–113. [PubMed]
Nutrients 2018, 10, 1489 17 of 18
38. Sangild, P.T.; Thymann, T.; Schmidt, M.; Stoll, B.; Burrin, D.G.; Buddington, R.K. Invited review: The preterm
pig as a model in pediatric gastroenterology. J. Anim. Sci. 2013, 91, 4713–4729. [CrossRef] [PubMed]
39. Andersen, A.D.; Sangild, P.T.; Munch, S.L.; van der Beek, E.M.; Renes, I.B.; Van Ginneken, C.; Greisen, G.O.;
Thymann, T. Delayed growth, motor function and learning in preterm pigs during early postnatal life.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2016, 310, R481–R492. [CrossRef] [PubMed]
40. Kilkenny, C.; Browne, W.J.; Cuthill, I.C.; Emerson, M.; Altman, D.G. Improving Bioscience Research
Reporting: The ARRIVE Guidelines for Reporting Animal Research. PLoS Biol. 2010, 8, e1000412. [CrossRef]
[PubMed]
41. Li, Y.; Jensen, M.L.; Chatterton, D.E.W.; Jensen, B.B.; Thymann, T.; Kvistgaard, A.S.; Sangild, P.T. Raw
bovine milk improves gut responses to feeding relative to infant formula in preterm piglets. Am. J. Physiol.
Gastrointest. Liver Physiol. 2014, 306, G81–G90. [CrossRef] [PubMed]
42. Østergaard, M.V.; Shen, R.L.; Støy, A.C.F.; Skovgaard, K.; Krych, Ł.; Leth, S.S.; Nielsen, D.S.; Hartmann, B.;
Bering, S.B.; Schmidt, M.; et al. Provision of Amniotic Fluid During Parenteral Nutrition Increases Weight
Gain With Limited Effects on Gut Structure, Function, Immunity, and Microbiology in Newborn Preterm
Pigs. J. Parenter. Enter. Nutr. 2016, 40, 552–566. [CrossRef] [PubMed]
43. Østergaard, M.V.; Bering, S.B.; Jensen, M.L.; Thymann, T.; Purup, S.; Diness, M.; Schmidt, M.; Sangild, P.T.
Modulation of Intestinal Inflammation by Minimal Enteral Nutrition With Amniotic Fluid in Preterm Pigs.
JPEN J. Parenter. Enter. Nutr. 2014, 38, 576–586. [CrossRef] [PubMed]
44. Krych, Ł.; Kot, W.; Bendtsen, K.M.B.; Hansen, A.K.; Vogensen, F.K.; Nielsen, D.S. Have you tried spermine?
A rapid and cost-effective method to eliminate dextran sodium sulfate inhibition of PCR and RT-PCR.
J. Microbiol. Methods 2018, 144, 1–7. [CrossRef] [PubMed]
45. Kaminarides, S.; Stamou, P.; Massouras, T. Comparison of the characteristics of set type yoghurt made from
ovine milk of different fat content. Int. J. Food Sci. Technol. 2007, 42, 1019–1028. [CrossRef]
46. Nguyen, D.N.; Jiang, P.; Frøkiær, H.; Heegaard, P.M.H.; Thymann, T.; Sangild, P.T. Delayed development
of systemic immunity in preterm pigs as a model for preterm infants. Sci. Rep. 2016, 6, 36816. [CrossRef]
[PubMed]
47. Choi, S.S.H.; Baldwin, N.; Wagner, V.O.; Roy, S.; Rose, J.; Thorsrud, B.A.; Phothirath, P.; Röhrig, C.H.
Safety evaluation of the human-identical milk monosaccharide sialic acid (N-acetyl-D-neuraminic acid) in
Sprague-Dawley rats. Regul. Toxicol. Pharmacol. 2014, 70, 482–491. [CrossRef] [PubMed]
48. Wang, B.; Yu, B.; Karim, M.; Hu, H.; Sun, Y.; McGreevy, P.; Petocz, P.; Held, S.; Brand-Miller, J. Dietary
sialic acid supplementation improves learning and memory in piglets. Am. J. Clin. Nutr. 2007, 85, 561–569.
[CrossRef] [PubMed]
49. Sakai, F.; Ikeuchi, Y.; Urashima, T.; Fujihara, M.; Ohtsuki, K.; Yanahira, S. Effects of Feeding Sialyllactose and
Galactosylated N-Acetylneuraminic Acid on Swimming Learning Ability and Brain Lipid Composition in
Adult Rats. J. Appl. Glycosci. 2006, 53, 249–254. [CrossRef]
50. Fleming, S.; Chichlowski, M.; Berg, B.; Donovan, S.; Dilger, R. Dietary Sialyllactose Does Not Influence
Measures of Recognition Memory or Diurnal Activity in the Young Pig. Nutrients 2018, 10, 395. [CrossRef]
[PubMed]
51. Nakano, T.; Sugawara, M.; Kawakami, H. Sialic acid in human milk: Composition and functions.
Acta Paediatr. Taiwan 2001, 42, 11–17. [PubMed]
52. Coppa, G.V.; Pierani, P.; Zampini, L.; Carloni, I.; Carlucci, A.; Gabrielli, O. Oligosaccharides in human milk
during different phases of lactation. Acta Paediatr. Suppl. 1999, 88, 89–94. [CrossRef] [PubMed]
53. Ten Bruggencate, S.J.; Bovee-Oudenhoven, I.M.; Feitsma, A.L.; van Hoffen, E.; Schoterman, M.H. Functional
role and mechanisms of sialyllactose and other sialylated milk oligosaccharides. Nutr. Rev. 2014, 72, 377–389.
[CrossRef] [PubMed]
54. Hansen, C.F.; Thymann, T.; Andersen, A.D.; Holst, J.J.; Hartmann, B.; Hilsted, L.; Langhorn, L.; Jelsing, J.;
Sangild, P.T. Rapid gut growth but persistent delay in digestive function in the postnatal period of preterm
pigs. Am. J. Physiol. Gastrointest. Liver Physiol. 2016, 310, G550–G560. [CrossRef] [PubMed]
55. Shen, Q.; Tuohy, K.M.; Gibson, G.R.; Ward, R.E. In vitro measurement of the impact of human milk
oligosaccharides on the faecal microbiota of weaned formula-fed infants compared to a mixture of prebiotic
fructooligosaccharides and galactooligosaccharides. Lett. Appl. Microbiol. 2011, 52, 337–343. [CrossRef]
[PubMed]
Nutrients 2018, 10, 1489 18 of 18
56. Tanaka, S.; Kobayashi, T.; Songjinda, P.; Tateyama, A.; Tsubouchi, M.; Kiyohara, C.; Shirakawa, T.;
Sonomoto, K.; Nakayama, J. Influence of antibiotic exposure in the early postnatal period on the development
of intestinal microbiota. FEMS Immunol. Med. Microbiol. 2009, 56, 80–87. [CrossRef] [PubMed]
57. Wong, J.M.; de Souza, R.; Kendall, C.W.; Emam, A.; Jenkins, D.J. Colonic health: Fermentation and short
chain fatty acids. J. Clin. Gastroenterol. 2006, 40, 235–243. [CrossRef] [PubMed]
58. Szylit, O.; Maurage, C.; Gasqui, P.; Popot, F.; Favre, A.; Gold, F.; Borderon, J.C. Fecal Short-Chain Fatty Acids
Predict Digestive Disorders in Premature Infants. J. Parenter. Enteral Nutr. 1998, 22, 136–141. [CrossRef]
[PubMed]
59. Arboleya, S.; Binetti, A.; Salazar, N.; Fernández, N.; Solís, G.; Hernández-Barranco, A.; Margolles, A.;
de los Reyes-Gavilán, C.G.; Gueimonde, M. Establishment and development of intestinal microbiota in
preterm neonates. FEMS Microbiol. Ecol. 2012, 79, 763–772. [CrossRef] [PubMed]
60. Favre, A.; Szylit, O.; Popot, F.; Catala, I.; Rondeau, C.; Maurage, C.; Gold, F.; Borderon, J.C.; Butel, M.J. Diet,
length of gestation, and fecal short chain fatty acids in healthy premature neonates. JPEN J. Parenter. Enteral Nutr.
2002, 26, 51–56. [CrossRef] [PubMed]
61. Ji, S.; Wang, F.; Chen, Y.; Yang, C.; Zhang, P.; Zhang, X.; Troy, F.A.; Wang, B. Developmental changes in the
level of free and conjugated sialic acids, Neu5Ac, Neu5Gc and KDN in different organs of pig: A LC-MS/MS
quantitative analyses. Glycoconj. J. 2017, 34, 21–30. [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
